Financial - Capital Markets
Compare Stocks
4 / 10Stock Comparison
COHN vs IIIV vs TYRA vs GAIN
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Biotechnology
Asset Management
COHN vs IIIV vs TYRA vs GAIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Financial - Capital Markets | Software - Infrastructure | Biotechnology | Asset Management |
| Market Cap | $87M | $506M | $1.77B | $657M |
| Revenue (TTM) | $278M | $223M | $0.00 | $90M |
| Net Income (TTM) | $14M | $16M | $-120M | $130M |
| Gross Margin | 93.8% | 60.4% | — | 68.6% |
| Operating Margin | 22.3% | 0.8% | — | 72.7% |
| Forward P/E | 3.3x | 20.3x | — | 40.7x |
| Total Debt | $450M | $8M | $6M | $456M |
| Cash & Equiv. | $57M | $67M | $77M | $14M |
COHN vs IIIV vs TYRA vs GAIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 21 | May 26 | Return |
|---|---|---|---|
| Cohen & Company Inc. (COHN) | 100 | 73.6 | -26.4% |
| i3 Verticals, Inc. (IIIV) | 100 | 94.6 | -5.4% |
| Tyra Biosciences, I… (TYRA) | 100 | 187.0 | +87.0% |
| Gladstone Investmen… (GAIN) | 100 | 119.0 | +19.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: COHN vs IIIV vs TYRA vs GAIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
COHN carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.48, yield 2.5%
- Rev growth 249.6%, EPS growth 55.4%
- Lower volatility, beta 0.48, current ratio 3.87x
- Beta 0.48, yield 2.5%, current ratio 3.87x
IIIV lags the leaders in this set but could rank higher in a more targeted comparison.
TYRA is the clearest fit if your priority is momentum.
- +260.4% vs IIIV's -13.8%
GAIN is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 319.3% 10Y total return vs TYRA's 26.5%
- 72.7% margin vs COHN's 5.2%
- 10.5% ROA vs TYRA's -38.4%, ROIC 5.3% vs -44.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 249.6% NII/revenue growth vs TYRA's -38.9% | |
| Value | Lower P/E (3.3x vs 40.7x) | |
| Quality / Margins | 72.7% margin vs COHN's 5.2% | |
| Stability / Safety | Beta 0.48 vs IIIV's 0.92 | |
| Dividends | 2.5% yield, 1-year raise streak, vs GAIN's 10.0%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +260.4% vs IIIV's -13.8% | |
| Efficiency (ROA) | 10.5% ROA vs TYRA's -38.4%, ROIC 5.3% vs -44.8% |
COHN vs IIIV vs TYRA vs GAIN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
COHN vs IIIV vs TYRA vs GAIN — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
COHN leads in 2 of 6 categories
GAIN leads 1 • IIIV leads 0 • TYRA leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
GAIN leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
COHN and TYRA operate at a comparable scale, with $278M and $0 in trailing revenue. GAIN is the more profitable business, keeping 72.7% of every revenue dollar as net income compared to COHN's 5.2%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $278M | $223M | $0 | $90M |
| EBITDAEarnings before interest/tax | $63M | $31M | -$132M | $58M |
| Net IncomeAfter-tax profit | $14M | $16M | -$120M | $130M |
| Free Cash FlowCash after capex | $26M | $10M | -$95M | -$82M |
| Gross MarginGross profit ÷ Revenue | +93.8% | +60.4% | — | +68.6% |
| Operating MarginEBIT ÷ Revenue | +22.3% | +0.8% | — | +72.7% |
| Net MarginNet income ÷ Revenue | +5.2% | +7.3% | — | +72.7% |
| FCF MarginFCF ÷ Revenue | +9.4% | +4.7% | — | +126.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -14.6% | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +5.4% | -78.0% | -32.6% | +58.1% |
Valuation Metrics
COHN leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 3.3x trailing earnings, COHN trades at a 92% valuation discount to IIIV's 40.9x P/E. On an enterprise value basis, COHN's 7.6x EV/EBITDA is more attractive than GAIN's 16.8x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $87M | $506M | $1.8B | $657M |
| Enterprise ValueMkt cap + debt − cash | $481M | $447M | $1.7B | $1.1B |
| Trailing P/EPrice ÷ TTM EPS | 3.27x | 40.91x | -16.37x | 9.28x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 20.30x | — | 40.66x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 7.65x | 14.02x | — | 16.82x |
| Price / SalesMarket cap ÷ Revenue | 0.31x | 2.37x | — | 7.31x |
| Price / BookPrice ÷ Book value/share | 0.82x | 1.51x | 7.57x | 1.22x |
| Price / FCFMarket cap ÷ FCF | 3.34x | 134.87x | — | 5.77x |
Profitability & Efficiency
COHN leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
GAIN delivers a 21.9% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $-41 for TYRA. IIIV carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to COHN's 4.37x. On the Piotroski fundamental quality scale (0–9), COHN scores 6/9 vs TYRA's 1/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +15.1% | +3.2% | -41.2% | +21.9% |
| ROA (TTM)Return on assets | +1.6% | +2.6% | -38.4% | +10.5% |
| ROICReturn on invested capital | +12.2% | +0.6% | -44.8% | +5.3% |
| ROCEReturn on capital employed | +7.6% | +0.7% | -43.3% | +6.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 1 | 4 |
| Debt / EquityFinancial leverage | 4.37x | 0.01x | 0.02x | 0.91x |
| Net DebtTotal debt minus cash | $393M | -$59M | -$72M | $441M |
| Cash & Equiv.Liquid assets | $57M | $67M | $77M | $14M |
| Total DebtShort + long-term debt | $450M | $8M | $6M | $456M |
| Interest CoverageEBIT ÷ Interest expense | 8.32x | 5.21x | — | 1.58x |
Total Returns (Dividends Reinvested)
Evenly matched — COHN and TYRA and GAIN each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GAIN five years ago would be worth $17,205 today (with dividends reinvested), compared to $6,442 for COHN. Over the past 12 months, TYRA leads with a +260.4% total return vs IIIV's -13.8%. The 3-year compound annual growth rate (CAGR) favors COHN at 45.3% vs IIIV's -0.8% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -31.3% | -9.3% | +22.8% | +20.7% |
| 1-Year ReturnPast 12 months | +106.3% | -13.8% | +260.4% | +30.8% |
| 3-Year ReturnCumulative with dividends | +206.8% | -2.5% | +143.7% | +56.5% |
| 5-Year ReturnCumulative with dividends | -35.6% | -27.6% | +26.5% | +72.0% |
| 10-Year ReturnCumulative with dividends | +156.3% | +24.9% | +26.5% | +319.3% |
| CAGR (3Y)Annualised 3-year return | +45.3% | -0.8% | +34.6% | +16.1% |
Risk & Volatility
Evenly matched — COHN and GAIN each lead in 1 of 2 comparable metrics.
Risk & Volatility
COHN is the less volatile stock with a 0.48 beta — it tends to amplify market swings less than IIIV's 0.92 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GAIN currently trades 96.3% from its 52-week high vs COHN's 43.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.48x | 0.92x | 0.75x | 0.53x |
| 52-Week HighHighest price in past year | $32.60 | $33.97 | $40.65 | $17.14 |
| 52-Week LowLowest price in past year | $7.78 | $19.89 | $8.75 | $13.11 |
| % of 52W HighCurrent price vs 52-week peak | +43.6% | +67.4% | +80.9% | +96.3% |
| RSI (14)Momentum oscillator 0–100 | 31.0 | 47.8 | 43.1 | 69.9 |
| Avg Volume (50D)Average daily shares traded | 28K | 292K | 1.1M | 371K |
Analyst Outlook
Evenly matched — COHN and GAIN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: IIIV as "Buy", TYRA as "Buy", GAIN as "Hold". Consensus price targets imply 53.5% upside for TYRA (target: $51) vs -9.1% for GAIN (target: $15). For income investors, GAIN offers the higher dividend yield at 10.05% vs COHN's 2.51%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $29.00 | $50.50 | $15.00 |
| # AnalystsCovering analysts | — | 14 | 7 | 7 |
| Dividend YieldAnnual dividend ÷ price | +2.5% | — | — | +10.0% |
| Dividend StreakConsecutive years of raises | 1 | — | — | 0 |
| Dividend / ShareAnnual DPS | $0.36 | — | — | $1.66 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +7.4% | 0.0% | 0.0% |
COHN leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). GAIN leads in 1 (Income & Cash Flow). 3 tied.
COHN vs IIIV vs TYRA vs GAIN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is COHN or IIIV or TYRA or GAIN a better buy right now?
For growth investors, Cohen & Company Inc.
(COHN) is the stronger pick with 249. 6% revenue growth year-over-year, versus -12. 9% for Gladstone Investment Corporation (GAIN). Cohen & Company Inc. (COHN) offers the better valuation at 3. 3x trailing P/E, making it the more compelling value choice. Analysts rate i3 Verticals, Inc. (IIIV) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — COHN or IIIV or TYRA or GAIN?
On trailing P/E, Cohen & Company Inc.
(COHN) is the cheapest at 3. 3x versus i3 Verticals, Inc. at 40. 9x. On forward P/E, i3 Verticals, Inc. is actually cheaper at 20. 3x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — COHN or IIIV or TYRA or GAIN?
Over the past 5 years, Gladstone Investment Corporation (GAIN) delivered a total return of +72.
0%, compared to -35. 6% for Cohen & Company Inc. (COHN). Over 10 years, the gap is even starker: GAIN returned +319. 3% versus IIIV's +24. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — COHN or IIIV or TYRA or GAIN?
By beta (market sensitivity over 5 years), Cohen & Company Inc.
(COHN) is the lower-risk stock at 0. 48β versus i3 Verticals, Inc. 's 0. 92β — meaning IIIV is approximately 92% more volatile than COHN relative to the S&P 500. On balance sheet safety, i3 Verticals, Inc. (IIIV) carries a lower debt/equity ratio of 1% versus 4% for Cohen & Company Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — COHN or IIIV or TYRA or GAIN?
By revenue growth (latest reported year), Cohen & Company Inc.
(COHN) is pulling ahead at 249. 6% versus -12. 9% for Gladstone Investment Corporation (GAIN). On earnings-per-share growth, the picture is similar: Cohen & Company Inc. grew EPS 55. 4% year-over-year, compared to -87. 9% for i3 Verticals, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — COHN or IIIV or TYRA or GAIN?
Gladstone Investment Corporation (GAIN) is the more profitable company, earning 72.
7% net margin versus 0. 0% for Tyra Biosciences, Inc. — meaning it keeps 72. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GAIN leads at 72. 7% versus 0. 0% for TYRA. At the gross margin level — before operating expenses — COHN leads at 93. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is COHN or IIIV or TYRA or GAIN more undervalued right now?
On forward earnings alone, i3 Verticals, Inc.
(IIIV) trades at 20. 3x forward P/E versus 40. 7x for Gladstone Investment Corporation — 20. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TYRA: 53. 5% to $50. 50.
08Which pays a better dividend — COHN or IIIV or TYRA or GAIN?
In this comparison, GAIN (10.
0% yield), COHN (2. 5% yield) pay a dividend. IIIV, TYRA do not pay a meaningful dividend and should not be held primarily for income.
09Is COHN or IIIV or TYRA or GAIN better for a retirement portfolio?
For long-horizon retirement investors, Gladstone Investment Corporation (GAIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
53), 10. 0% yield, +319. 3% 10Y return). Both have compounded well over 10 years (GAIN: +319. 3%, IIIV: +24. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between COHN and IIIV and TYRA and GAIN?
These companies operate in different sectors (COHN (Financial Services) and IIIV (Technology) and TYRA (Healthcare) and GAIN (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: COHN is a small-cap high-growth stock; IIIV is a small-cap quality compounder stock; TYRA is a small-cap quality compounder stock; GAIN is a small-cap deep-value stock. COHN, GAIN pay a dividend while IIIV, TYRA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.